21VALUE-Dx investigates HTA, Reimbursement and Pricing of Diagnostic Tests for CA-ARTIApril 21, 2021/in News/by Leandra
23Enhancing the quality of antibiotic prescribing for CA-ARTI in Emergency Rooms through ADEQUATE trialMarch 31, 2021/in News/by Leandra
25The third PPAS captures information on care delivery and patient management during COVID-19 pademicMarch 29, 2021/in News/by Leandra
26VALUE-Dx assesses diagnostic accuracy of point-of-care tests in community settings for lower CA-ARTIMarch 29, 2021/in News/by Leandra
27VALUE-Dx developed sample collection and management manuals for trialsMarch 26, 2021/in News/by Leandra
29ESCMID Policy Statement: addressing the lack of availability of existing antibioticsNovember 26, 2020/in News/by Leandra